全文获取类型
收费全文 | 3253095篇 |
免费 | 272383篇 |
国内免费 | 14144篇 |
专业分类
耳鼻咽喉 | 44691篇 |
儿科学 | 99472篇 |
妇产科学 | 83443篇 |
基础医学 | 518379篇 |
口腔科学 | 88786篇 |
临床医学 | 290878篇 |
内科学 | 566675篇 |
皮肤病学 | 86323篇 |
神经病学 | 282334篇 |
特种医学 | 128688篇 |
外国民族医学 | 209篇 |
外科学 | 509299篇 |
综合类 | 103203篇 |
现状与发展 | 26篇 |
一般理论 | 2387篇 |
预防医学 | 276519篇 |
眼科学 | 73914篇 |
药学 | 224490篇 |
23篇 | |
中国医学 | 9371篇 |
肿瘤学 | 150512篇 |
出版年
2021年 | 55254篇 |
2020年 | 35257篇 |
2019年 | 58281篇 |
2018年 | 71141篇 |
2017年 | 54274篇 |
2016年 | 59890篇 |
2015年 | 74188篇 |
2014年 | 108594篇 |
2013年 | 174079篇 |
2012年 | 92257篇 |
2011年 | 91798篇 |
2010年 | 116422篇 |
2009年 | 121144篇 |
2008年 | 78748篇 |
2007年 | 82168篇 |
2006年 | 92682篇 |
2005年 | 88736篇 |
2004年 | 90759篇 |
2003年 | 81572篇 |
2002年 | 70802篇 |
2001年 | 84595篇 |
2000年 | 76641篇 |
1999年 | 80538篇 |
1998年 | 63687篇 |
1997年 | 61968篇 |
1996年 | 59670篇 |
1995年 | 55156篇 |
1994年 | 49493篇 |
1993年 | 46232篇 |
1992年 | 57605篇 |
1991年 | 54842篇 |
1990年 | 52059篇 |
1989年 | 51570篇 |
1988年 | 48379篇 |
1987年 | 47311篇 |
1986年 | 45070篇 |
1985年 | 45700篇 |
1984年 | 43762篇 |
1983年 | 40451篇 |
1982年 | 40473篇 |
1981年 | 38284篇 |
1980年 | 36222篇 |
1979年 | 37012篇 |
1978年 | 33659篇 |
1977年 | 30977篇 |
1976年 | 28156篇 |
1975年 | 26692篇 |
1974年 | 27807篇 |
1973年 | 26717篇 |
1972年 | 25119篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
Zinc sulfate addition to glass-ionomer-based cements: influence on physical and antibacterial properties, zinc and fluoride release. 总被引:5,自引:0,他引:5
Prudencio W R Osinaga Rosa Helena M Grande Rafael Y Ballester Maria Regina L Simionato Célia Regina M Delgado Rodrigues Antonio Muench 《Dental materials》2003,19(3):212-217
OBJECTIVES: The aim of this study is to evaluate the effect of ZnSO(4) addition to a conventional glass ionomer and a resin-modified glass ionomer on solubility, flexural strength, zinc and fluoride (F) release, and Streptococcus mutans growth inhibition. METHODS: 5 or 10% ZnSO(4) was added to Vitremer and Ketac-Fil powders. Solubility test was performed based on ISO 7489. Flexural strength was determined by 3-point bending test based on ISO 4049. Zn release/uptake was determined by atomic emission spectrometry; F release/uptake was measured using a F-specific electrode. Both release measurements were performed for 15 d before and 15 d after recharging. Antibacterial test was conducted according to agar plate methods against S. mutans, by measuring the inhibition halos in 1-h and 15-d specimens. Data were analyzed by ANOVA. RESULTS: Solubility increased with higher ZnSO(4) content, but remained below the ISO 7489 limit. Flexural strength was not affected by ZnSO(4) addition, and Vitremer performed better than Ketac-Fil. The control materials released no zinc. Vitremer with 10% ZnSO(4) released the highest amount of zinc. Fluoride release was similar for Ketac-Fil and Vitremer. In both cases, the highest amounts were released in the first 24 h. The growth inhibition halo of S. mutans was similar for both materials with highest content of ZnSO(4) and occurred only with 1-h specimens. SIGNIFICANCE: Zinc addition decreased microorganisms growth and improved fluoride release, without significantly affecting the materials' flexural strength and solubility. 相似文献
995.
996.
Dr. med. Dr. jur. R. Erlinger 《Der Onkologe》2003,9(8):865-868
Ohne Zusammenfassung 相似文献
997.
Daoyan Wei Henry Q. Xiong James L. Abbruzzese Keping Xie 《Journal of gastrointestinal cancer》2003,33(1):43-60
Pancreatic cancer is a lethal disease characterized by early metastasis, local invasion, and resistance to conventional therapies. To understand its etiology and eventually make prevention of it possible and effective, appropriate carcinogenesis models will certainly help us understand the effects of environmental and genetic elements on pancreatic carcinogenesis. The development of new treatment strategies to control cancer metastasis is of immediate urgency. Fulfillment of this task relies on our knowledge of the cellular and molecular biology of pancreatic cancer metastasis and the availability of biologically and clinically relevant model systems. Many of the existing pancreatic cancer carcinogenesis and metastasis animal models are described in this review. The advantages and disadvantages of each model and their clinical implications are discussed, and special attention is focused on experimental therapeutic strategies targeting pancreatic cancer metastasis. 相似文献
998.
Burkitt’s lymphoma is a high-grade, rapidly growing B-cell neoplasm. It is recognized by its aggressive course, brief median survival, and low rates of long-term survival. The authors discuss the case of a patient who acutely presented with intraabdominal complications from a new onset of Burkitt’s lymphoma. The clinical and pathological features, staging, treatment options, and survival data are reviewed. In addition, the role of surgical intervention is carefully analyzed. 相似文献
999.
肝癌间质及癌旁病变的病理分析 总被引:2,自引:0,他引:2
目的 研究肝癌间质及癌旁病变的临床病理意义。方法 在 2 0例肝癌组织标本中取 45个癌结节 ,分别在癌结节中间、癌旁肝组织等部位取组织 4块 ,连续切片 ,显微镜下观察。结果 19个结节有完整窦内皮细胞围绕癌巢 ,其中癌结节肉眼小于3cm者 13个 ,大于 3cm者 6个。 2 6个癌结节无完整窦内皮细胞围绕癌巢 ,其中癌结节直径大于 3cm者 2 4个 ,小于 3cm者 2个。2 0例中有 13例合并肝硬化 ,17例有乙型肝炎病毒感染和HBsAg阳性。 结论 病理连续切片 ,显微镜下观察肝癌间质及癌旁病变是预测肝癌患者预后的重要病理学指标 相似文献
1000.
Manuel Steiner Andishe Attarbaschi Margit K nig Helmut Gadner Oskar A. Haas Georg Mann 《Pediatric hematology and oncology》2004,22(1):11-16
Constitutional trisomy 21 is the most prominent predisposing factor to childhood leukemia, whereas the t(12;21)(p13;q22) with its molecular genetic counterpart, the TEL/AML1 fusion gene, is the most common acquired chromosomal rearrangement in childhood B-cell precursor (BCP) acute lymphoblastic leukemia (ALL). Thus, it was somewhat surprising that according to the currently available literature the incidence of TEL/AML1+ BCP ALL is extremely low in patients with Down syndrome (DS). To further investigate this issue in a population-based fashion, the authors retrospectively assessed the number of DS patients with a TEL/AML1+ ALL in two consecutive Austrian ALL multicenter trials. Accordingly, they were able to analyze 8 of 10 individuals with DS and a BCP ALL, including 2 who suffered from a TEL/AML1+ leukemia. Based on this observation we concluded that individuals with a constitutional trisomy 21 may have the similar likelihood to develop a TEL/AML1+ leukemia as BCP ALL patients without this specific predisposing factor. 相似文献